Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF

Plain-language summary

This study examines the effect of intensive cholecalciferol (vitamin D) monitoring and supplementation on blood vitamin D levels in pediatric patients with cystic fibrosis. It enrolled children diagnosed with cystic fibrosis. The study was conducted in Phase 4 and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Phase 4

Status

Completed

Sponsor

Hospital Infantil de Mexico Federico Gomez

Intervention

Cholecalciferol Pill

Start date

6/22/2022

Estimated completion

1/30/2025

Countries

Mexico

Related genes

Locations

• Mexico City, Mexico

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Cystic Fibrosis

Exclusion Criteria:

* Another chronic disease (HIV, cancer, renal failure)
* 25-OH-VitD levels \< 10 ng/ml or \> 30 ng/ml